Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service hernia repair cases in Indiana: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (255 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 49 | 5,139 | 35% |
| 2020 | 34 | 4,118 | 39% |
| 2021 | 36 | 4,224 | 44% |
| 2022 | 34 | 4,093 | 47% |
| 2023 | 35 | 3,998 | 51% |
| 2024 | 39 | 4,058 | 53% |
| 2025 from claims | – | 4,342 3,985–4,594 | 54% |
| 2026 forecast | – | 4,385 3,858–5,060 | 55% |
| 2027 forecast | – | 4,412 3,772–5,258 | 55% |
| 2028 forecast | – | 4,438 3,703–5,434 | 56% |
| 2029 forecast | – | 4,463 3,645–5,597 | 57% |
| 2030 forecast | – | 4,487 3,595–5,751 | 57% |
Open, laparoscopic, and robotic ventral and inguinal hernia repair. Professional codes (what the surgeon bills): CPT 49505, 49650, 49651, 49560, 49561, 49565, 49566, 49570, 49572, 49585, 49587, 49590, 49652, 49653, 49654, 49655, 49656, 49657, 49591, 49592, 49593, 49594, 49595, 49596, 49613, 49614, 49615, 49616, 49617, 49618, 49621, 49622; the hospital bills MS-DRG 353, 354, 355.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 37% of the cases CMS names in Indiana; 29 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 11% inpatient hospital, 78% hospital outpatient, 11% surgery center. The share outside the hospital has moved −3 pts since 2019.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Illinois | 88 | 7,166−3.6%/yr | −3.6%/yr | 5.5 | 7% | 8,010 in 2030+1.9%/yr |
| Ohio | 75 | 6,844−3.3%/yr | −3.3%/yr | 6.6 | 5% | 7,430 in 2030+1.4%/yr |
| Michigan | 38 | 4,810−7%/yr | −7%/yr | 6.1 | 4% | 4,960 in 2030+0.5%/yr |
| Missouri | 51 | 4,103−3.2%/yr | −3.2%/yr | 7.0 | 3% | 5,000 in 2030+3.4%/yr |
| Wisconsin | 34 | 3,364−3.4%/yr | −3.4%/yr | 6.4 | 3% | 3,770 in 2030+1.9%/yr |
| Minnesota | 18 | 2,581−3.2%/yr | −3.2%/yr | 6.1 | 8% | 3,830 in 2030+6.8%/yr |
| Kansas | 27 | 2,322−2.7%/yr | −2.7%/yr | 6.0 | 12% | 2,400 in 2030+0.5%/yr |
| Iowa | 22 | 1,777−4.7%/yr | −4.7%/yr | 4.2 | 7% | 1,970 in 2030+1.7%/yr |
| Nebraska | 17 | 1,596−3.4%/yr | −3.4%/yr | 6.4 | 14% | 1,920 in 2030+3.1%/yr |
| South Dakota | 6 | 763−5.7%/yr | −5.7%/yr | 6.1 | 0% | 930 in 2030+3.3%/yr |
| North Dakota | 7 | 627−1.4%/yr | −1.4%/yr | 6.6 | 0% | 580 in 2030−1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cholecystectomy & appendectomy | 69 | 3,309−4.8%/yr | −4.8%/yr | 4.81.1× | 5% | 3,260 in 2030−0.3%/yr |
| Colorectal resection | 3 | 1,174−6.4%/yr | −6.4%/yr | 1.71.0× | 0% | 1,190 in 2030+0.2%/yr |
| Antireflux & hiatal hernia surgery | 9 | 580−0.9%/yr | −0.9%/yr | 0.81.1× | 0% | 630 in 2030+1.3%/yr |
| Breast reconstruction | 0 | 272−5%/yr | −5%/yr | 0.40.9× | 23% | 190 in 2030−6.1%/yr |
| Bariatric surgery | 0 | 105−16%/yr | −16%/yr | 0.10.7× | 0% | 90 in 2030−1.8%/yr |
Hernia repair in every state, and its device makers · Every procedure market in Indiana · Every state · Compare with Illinois
Tela Bio leads with 89% of company spending on these surgeons in 2025, −5 pts on 2024.
In 2025, 7 companies reported engagement with Indiana’s surgeons worth $406K in consulting, speaking, meals and travel tied to these products, about $10K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 5 clearances and approvals in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.